Christine Ribic

Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer

Christine Ribic, Daniel J. Sargent, Malcolm J. Moore et al. · New England Journal of Medicine · 2003 · 2.1K citations · Full text

High-frequency Microsatellite Instability, Immunology, Adjuvant Chemotherapy +16

Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

Daniel J. Sargent, Silvia Marsoni, Geneviève Monges et al. · Journal of Clinical Oncology · 2010 · 1.6K citations · Full text

Confirmation of deficient mismatch repair (dMMR) as a predictive marker for lack of benefit from 5-FU based chemotherapy in stage II and III colon cancer (CC): A pooled molecular reanalysis of randomized chemotherapy trials

Daniel J. Sargent, Silvia Marsoni, S. N. Thibodeau et al. · Journal of Clinical Oncology · 2008 · 92 citations

Surgical Oncology, Cancer Management, Immunology +19

Statin-Associated Rhabdomyolysis: Is There a Dose-Response Relationship?

Anne Holbrook, M. S. Wain Wright, Melani Sung et al. · Canadian Journal of Cardiology · 2011 · 76 citations

Therapeutic Drug Monitoring, Statin-associated Rhabdomyolysis, Medicine +2

The Risk of Cardiovascular Disease Is Not Increasing Over Time Despite Aging and Higher Comorbidity Burden of Kidney Transplant Recipients

Ngan N. Lam, S. Joseph Kim, Greg Knoll et al. · Transplantation · 2016 · 65 citations